Sleep-wake effects of yohimbine and atropine in rats with a clomipramine-based model of depression

NeuroReport

Volumn 13, Issue 13, 2002, Pages 1603-1606

  Mavanji, Vijayakumar ^a,b   Datta, Subimal ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Animal model; Atropine; Endogenous depression; REM sleep; Yohimbine

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOMIPRAMINE; SODIUM CHLORIDE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP DISORDER; SLEEP WAKING CYCLE;

EID: 0037120279     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200209160-00006     Document Type: Article

References (25)

1. Sharpley AL and Cowen PJ. Biol Psychiatry 37, 85-98 (1995).
2. Reynolds CF and Kupfer DJ. Sleep 10, 199-215 (1987).
3. Schildkraut JJ. Am J Psychiatry 122, 509-522 (1965).
4. Janowsky DS and Overstreet DH. The role of acetylcholine in mood disorders. In: Bloom FE and Kupfer DJ, eds. Psychopharmacology, The Fourth Generation of Progress. New York: Raven Press; 1995, pp. 945-956.
5. Lambert G, Johanson M, Agren H et al. Arch Gen Psychiatry 57, 787-793 (2000).
6. Bunney WE and Davis JM. Arch Gen Psychiatry 13, 483-491 (1965).
7. Delgado PL, Miller HL and Salomon RL. Psychopharmacology 29, 389-396 (1993).
8. Mongeau R, Blier P and de Montigny C. Brain Res Rev 23, 145-195 (1997).
9. Ordaway GA, Smith KS and Haycock JW. J Neurochem 62, 680-685 (1994).
10. Sitaram N and Gillin JC. Biol Psychiatry 18, 467-475 (1980).
11. Risch C, Janowsky DS, Gillin JC et al. Psychopharmacol Bull 4, 89-94 (1983).
12. Dilsaver SC. J Clin Pharmacol 6, 65-74 (1986).
13. Stall A, Cohen BN and Hanin I. Biol Psychiatry 29, 309-321 (1991).
14. Kelose J Jr, Gillin J, Janowsky DS et al. N Eng J Med 312, 861-862 (1985).
15. Vogel GW, Neil D, Hagler M et al. Neurosci Biobehav Rev 14, 85-91 (1990).
16. Redmond AM and Leonard BE. Hum Psychopharmacol 12, 407-430 (1997).
17. Mavanji VK and Meti BL. Neurochem Res 24, 345-349 (1999).
18. Prathiba J, Kumar KB and Karanth KS. Brain Res 867, 243-245 (2000).
19. Hobson JA, Pace-Schott EF and Stickgold R. Behav Brain Sci 23, 793-1121 (2000).
20. Python A, Charnay Y, Mikolajewski R et al. Pharmacol Biochem Behav 58(2), 369-372 (1997).
21. Datta S. Neurosci Biobehav Rev 19, 67-84 (1995).
22. Holmes BB, Raddy JJ and Fujimoto JM. Proc Soc Exp Biol Med 218, 334-340 (1998).
23. Ishiura Y, Yoshiama M, Namiki M et al. J Pharmacol Exp Ther 297, 933-939 (2001).
24. Datta S and Hobson JA. Behav Neurosci 114, 1239-1244 (2000).
25. Clark JT, Smith ER and Davidson JM. Neuroendocrinology 41, 36-43 (1985).